These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 2573487)

  • 1. Active moiety of sulfasalazine.
    Greenwell BE
    Dig Dis Sci; 1989 Nov; 34(11):1804-5. PubMed ID: 2573487
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy of treatment for ulcerative colitis.
    Steinberg H
    JAMA; 1998 Aug; 280(5):422. PubMed ID: 9701075
    [No Abstract]   [Full Text] [Related]  

  • 3. [Inhibition of intestinal leukotriene formation as a possible mechanism of action of sulfasalazine, 5-aminosalicylic acid and 4-aminosalicylic acid].
    Peskar BM
    Klin Wochenschr; 1988 Nov; 66(22):1147-50. PubMed ID: 2907066
    [No Abstract]   [Full Text] [Related]  

  • 4. Oral mesalamine for ulcerative colitis.
    Med Lett Drugs Ther; 1992 Aug; 34(877):80-1. PubMed ID: 1353858
    [No Abstract]   [Full Text] [Related]  

  • 5. [Salazosulfapyridine or 5-aminosalicylic acid].
    van Hees PA
    Ned Tijdschr Geneeskd; 1987 May; 131(22):931-4. PubMed ID: 2885762
    [No Abstract]   [Full Text] [Related]  

  • 6. Sulfasalazine and new analogues.
    Friedman G
    Am J Gastroenterol; 1986 Feb; 81(2):141-4. PubMed ID: 2868653
    [No Abstract]   [Full Text] [Related]  

  • 7. [Exacerbation of ulcerative colitis and Crohn's disease following a change-over from salazosulfapyridine to 5-aminosalicylic acid].
    Feurle GE; Helmstädter V
    Dtsch Med Wochenschr; 1986 May; 111(18):721-2. PubMed ID: 2870908
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparable efficacy of oral 5-aminosalicylic acid (Mesasal) and sulfasalazine in maintaining ulcerative colitis in remission.
    Eliakim R; Wengrower D; Ligumsky M; Rachmilewitz D
    Isr J Med Sci; 1990 Jan; 26(1):47-9. PubMed ID: 1968895
    [No Abstract]   [Full Text] [Related]  

  • 9. Comment: mesalamine in ulcerative colitis.
    Rothbart D
    DICP; 1991 Sep; 25(9):1015-6. PubMed ID: 1683077
    [No Abstract]   [Full Text] [Related]  

  • 10. Will there be a next generation of sulfasalazine?
    Goldman P
    Gastroenterology; 1982 Nov; 83(5):1138-41. PubMed ID: 6126420
    [No Abstract]   [Full Text] [Related]  

  • 11. Sulfasalazine revisited: a meta-analysis of 5-aminosalicylic acid in the treatment of ulcerative colitis.
    Sutherland LR; May GR; Shaffer EA
    Ann Intern Med; 1993 Apr; 118(7):540-9. PubMed ID: 8095128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rolling review: inflammatory bowel disease.
    Carpani de Kaski M; Hodgson HJ
    Aliment Pharmacol Ther; 1993 Oct; 7(5):567-79. PubMed ID: 7904189
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of chronic inflammatory intestinal diseases with 5-aminosalicylic acid].
    Malchow H
    Internist (Berl); 1987 Jan; 28(1):14-20. PubMed ID: 2883152
    [No Abstract]   [Full Text] [Related]  

  • 14. [The treatment of ulcerative colitis].
    Turunen U; Järvinen HJ
    Duodecim; 1993; 109(2):145-51. PubMed ID: 7912179
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of ulcerative colitis with oral mesalamine: advances in drug formulation, efficacy expectations and dose response, compliance, and chemoprevention.
    Sandborn WJ
    Rev Gastroenterol Disord; 2006; 6(2):97-105. PubMed ID: 16699478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Current medical treatment of hemorrhagic rectocolitis].
    Gendre JP
    Gastroenterol Clin Biol; 1994; 18(2 Pt 3):T9-12. PubMed ID: 7913901
    [No Abstract]   [Full Text] [Related]  

  • 17. Mesalamine and olsalazine: 5-aminosalicylic acid agents for the treatment of inflammatory bowel disease.
    Segars LW; Gales BJ
    Clin Pharm; 1992 Jun; 11(6):514-28. PubMed ID: 1600685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Aminosalicylates in chronic inflammatory intestinal diseases and rheumatoid arthritis].
    Maier KP
    Dtsch Med Wochenschr; 1992 Oct; 117(42):1614-5. PubMed ID: 1356747
    [No Abstract]   [Full Text] [Related]  

  • 19. Sulfasalazine and new analogues in inflammatory bowel disease, with focus on Crohn's disease.
    van Hees PA
    Acta Gastroenterol Belg; 1987; 50(5):555-9. PubMed ID: 2902723
    [No Abstract]   [Full Text] [Related]  

  • 20. Adverse effects of sulfasalazine and treatment of ulcerative colitis with mesalazine.
    Nakajima H; Munakata A; Yoshida Y
    J Gastroenterol; 1995 Nov; 30 Suppl 8():115-7. PubMed ID: 8563870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.